FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects

W Wang, X Liu, L Zhao, K Jiang, Z Yu… - Frontiers in …, 2024 - frontiersin.org
F-box and WD repeat domain-containing 7 (FBXW7), formerly known as hCdc4, hAGO
Fbw7, or SEL10, plays a specific recognition function in SCF-type E3 ubiquitin ligases …

MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT pathway

L Zhang, Z Tong, Z Sun, G Zhu, E Shen… - Bioscience …, 2020 - portlandpress.com
Background: Esophageal cancer (EC) is one of the most common malignant tumors of the
digestive system. MiR-25-3p was proved to be a biomarker for the diagnosis and treatment …

[HTML][HTML] Prognosis value of heat-shock proteins in esophageal and esophagogastric cancer: A systematic review and meta-analysis

ET Nakamura, A Park, MA Pereira… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Heat shock proteins (HSPs) are molecular chaperones that play an
important role in cellular protection against stress events and have been reported to be …

Esophageal cancer: A global challenge requiring tailored strategies

CY Cheng, WR Hao, TH Cheng - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
In this editorial we comment on the article published in a recent issue of the World Journal of
Gastrointestinal Oncology. Characterized by high mortality rates and geographical variations …

Machine learning and novel biomarkers associated with immune infiltration for the diagnosis of esophageal squamous cell carcinoma

J Zhang, N Zhang, X Yang, X Xin, C Jia, S Li… - Journal of …, 2022 - Wiley Online Library
Esophageal squamous cell carcinoma (ESCC) accounts for the main esophageal cancer
type, which is related to advanced stage and poor survivals. Therefore, novel diagnostic …

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study

RQ Zhou, J Luo, LJ Li, M Du, QC Wu - BMC surgery, 2023 - Springer
Background Neoadjuvant therapy is recommended to improve the prognosis of
oesophageal squamous cell carcinoma (ESCC). As a PD-1 inhibitor developed in China …

Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma

R Zhang, J Liu, H Yang, J Tan… - … in Cancer Research …, 2024 - journals.sagepub.com
Background A clinical challenge in esophageal squamous cell carcinoma (ESCC) remains
the lack of applicable plasma biomarkers for screening and diagnosis. Circular RNAs …

[HTML][HTML] Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer

J Zhang, Y Zhou, B Zhang, C Wang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background F-box protein 45 (FBXO45) is a member of the F-box protein family, and is
reportedly involved in the progression of many diseases. However, its role in esophageal …

[HTML][HTML] Circ_0003855 involvement of esophageal cancer progression through miR-622/FLOT1

J Tian, X Hu, X Zhang - Oncology Research, 2024 - ncbi.nlm.nih.gov
To confirm the relationship between Circ_0003855 and EC, we purchased the Human
esophageal carcinoma cell line Eca109 and normal human esophageal epithelial cells …

Impact of Extracellular Matrix‐Related Genes on the Tumor Microenvironment and Prognostic Indicators in Esophageal Cancer: A Comprehensive Analytical Study

Y Wu, W Hu, Z Jia, Q Zhu, J Xu, L Peng… - Genetics …, 2024 - Wiley Online Library
Esophageal cancer is a major global health challenge with a poor prognosis. Recent studies
underscore the extracellular matrix (ECM) role in cancer progression, but the full impact of …